Skip to main navigation
Skip to search
Skip to main content
Taipei Medical University Home
Help & FAQ,
Link opens in a new tab
English
中文
Search content at Taipei Medical University
Home
Profiles
Research units
Projects
Research output
Datasets
Activities
Additional file 1: of Monospecific antibody targeting of CDH11 inhibits epithelial-to-mesenchymal transition and represses cancer stem cell-like phenotype by up-regulating miR-335 in metastatic breast cancer, in vitro and in vivo
Jia Hong Chen
(Creator)
Wen Chien Huang
(Contributor)
Oluwaseun Adebayo Bamodu
(Contributor)
Peter M H Chang
(Creator)
Tsu-Yi Chao
(Contributor)
Tse Hung Huang
(Contributor)
Taipei Medical University Shuang Ho Hospital
TMU Research Center of Cancer Translational Medicine
International Master Program in Medicine
Department of Internal Medicine
Graduate Institute of Clinical Medicine
Dataset
Overview
Research output
(1)
Research output
Research output per year
2019
2019
2019
1
Article
Research output per year
Research output per year
1 results
Publication Year, Title
(descending)
Publication Year, Title
(ascending)
Title
Type
Filter
Article
Search results
2019
Monospecific antibody targeting of CDH11 inhibits epithelial-to-mesenchymal transition and represses cancer stem cell-like phenotype by up-regulating miR-335 in metastatic breast cancer, in vitro and in vivo
Chen, J. H., Huang, W. C., Bamodu, O. A., Chang, P. M. H.,
Chao, T. Y.
& Huang, T. H.,
Jun 27 2019
,
In:
BMC Cancer.
19
,
1
, 5811.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
Mesenchymal-Epithelial Transition
100%
CDH11
100%
Cancer Stem Cell
100%
Catenin
25%
Vimentin
16%
35
Link opens in a new tab
Citations (Scopus)